Macrae D (2015) Targeting Glycemic Control After Pediatric Cardiac Surgery*, Pediatric Critical Care Medicine, 10.1097/PCC.0000000000000556, 16:9, (887-888), Online publication date: 1-Nov-2015. Gaies ...

Despite their widespread use, direct comparative data on the efficacy and safety of rhTPO, romiplostim, and eltrombopag in pediatric ITP remain scarce. Existing evidence is predominantly derived from ...

A firearm safety program for families of pediatric ED patients with behavioral health concerns increased firearm storage screenings and resource distribution. A quality improvement (QI) initiative in ...

Crying during vaccinations and sibling number were not associated with MRI success.Parental presence significantly improved non-sedated MRI success in children aged 3-6 years. Compared to other ...

ABSTRACT. Introduction: The shortage of pediatric medications is particularly concerning due to the lack of pediatric-specific labeling and limited alternatives, reducing the therapeutic options and ...

Safety and efficacy of the EZH1/2 inhibitor valemetostat tosylate (DS-3201b) in pediatric patients with malignant solid tumors (NCCH1904): A multicenter phase I trial. Authors : Ayumu Arakawa , Kanako ...

No reported TEAE led to dose reduction, discontinuation or death. No new safety signal was observed. Conclusions: Overall, luvometinib was well-tolerated and demonstrated promising anti-tumor activity ...

Find out about controversies surrounding the safety of MRI imaging in pacemaker patients and the potential benefits of the new MRI-conditional technology. News & Perspective Drugs & Diseases ...

The U.S. Food and Drug Administration (FDA) granted approval for antihemophilic factor [recombinant], PEGylated-aucl (Jivi ®) for use in children aged 7 to under 12 years with severe hemophilia A, ...